Novel nasal spray effectively prevents influenza infection
The nasal spray reduced influenza virus levels by >99.99 percent, which could safeguard public health if validated in humans.
List view / Grid view
The nasal spray reduced influenza virus levels by >99.99 percent, which could safeguard public health if validated in humans.
The vaccine provided complete protection with no detectable virus in the lungs and could be a routine part of people’s medical treatment.
This report provides insights into current research and future prospects from potential breakthroughs to global collaboration in pandemic preparedness.
A new study shows that changes in clonal dominance characterises T-cell memory against multiple COVID-19 variants following mRNA vaccinations.
Proteins regulating plasminogen-plasmin levels can be used to identify patients at risk of progressing to a severe stage of COVID-19.
As humanity faces an impending era of pandemics, global collaboration among governments, organisations and industry is critical. In this article, epidemiologist Dr Jay Varma explores the urgent need for researching and developing drugs to combat a range of epidemic-prone pathogens, and reflects on the increased risk of spillovers and the…
The new study’s findings suggest that CRS can be treated with an IL-6 receptor antibody that has a short half-life.
In this article, David Bardsley, Commercial Director, and Nick Foster, Vice President of Discovery CRO at Cresset, explore the challenges that occur when approaching drug discovery in silos and how harnessing advances in technology can help to overcome them.
WEHI researchers have found that a genetic change of MLKL increases risk of uncontrolled inflammatory response
Commercially available mass spectrometers offer a reliable means of detecting the SARS-CoV-2 coronavirus.
Researchers have shown insights into the omicron variants of the SARS-CoV-2 virus, which have rapidly disseminated globally in the past year.
Receiving a COVID-19 vaccination could offer a dual benefit by not only lowering the likelihood of developing long-haul COVID but also mitigating symptoms for individuals already dealing with this condition.
Since the onset of the COVID-19 pandemic caused by the SARS-CoV-2 virus, scientists have been striving to comprehend the underlying reasons for the virus's distinctive and detrimental long-term impacts, distinct from most other coronaviruses.
A new discovery presents a bioinformatic approach for improving vaccine effectiveness against infectious agents such as COVID-19.
The University of California underwent a mouse study disclosing underlying sex differences in mice for obesity.